EPIC | INDV |
Sector | Pharma and Biotech |
ISIN | GB00BN4HT335 |
Market Sector | MAIN |
Market Segment | STMM |
Main Indices | FTSE 250, FTSE 350, FTSE All-Share |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £1,936.00m |
NMS | 7,500 |
Shares in issue | 135.38m |
Date Listed | n/a |
Currency | UK Pounds |
Share Price | 1,430.00p |
Change Today | 2.00p |
% Change | 0.14 % |
52 Week High | 1,885.00 |
52 Week Low | 1,135.00 |
Volume | 6,477 |
Shares Issued | 135.38m |
Market Cap | £1,936.00m |
Beta | 0.02 |
RiskGrade | 314 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
08:00 | 6 @ 1,428.00p |
08:00 | 4 @ 1,428.00p |
08:00 | 3 @ 1,428.00p |
08:00 | 3 @ 1,428.00p |
08:00 | 3 @ 1,428.00p |
CEO | Mark Crossley |
Chair | Graham Hetherington |
You are here: research